VeriMomVeriMom
HIGH RISK

임신 중 dimethyl imidazolidinone을 피해야 할까요? | VeriMom

Multiple supplier SDS and registration records list 1,3‑dimethyl‑2‑imidazolidinone (CAS 80‑73‑9, also called dimethylimidazolidinone, DMI) as Reproductive Toxicity Category 2 (H361, “suspected of damaging fertility or the unborn child”), and ECHA’s Registry of CLH intentions shows a CLH proposal has been submitted for this substance. These items support a suspected reproductive hazard (H361 → h=2) though a legally binding harmonised CLH entry does not appear to be published as an adopted harmonised classification yet; mechanistic data are limited, so mechanism is scored as theoretical only. DMI is a low‑molecular‑weight polar solvent with measurable dermal absorption in typical solvent roles, so topical cosmetic exposure is assessed as moderate. (Sources: ECHA substance page; ECHA Registry of CLH intentions; supplier SDS/C&L notifications; EWG summary).

ECHA regulatory hazard statements

  • H361

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

dimethyl imidazolidinone은 임신 중 안전한가요?
Multiple supplier SDS and registration records list 1,3‑dimethyl‑2‑imidazolidinone (CAS 80‑73‑9, also called dimethylimidazolidinone, DMI) as Reproductive Toxicity Category 2 (H361, “suspected of damaging fertility or the unborn child”), and ECHA’s Registry of CLH intentions shows a CLH proposal has been submitted for this substance. These items support a suspected reproductive hazard (H361 → h=2) though a legally binding harmonised CLH entry does not appear to be published as an adopted harmonised classification yet; mechanistic data are limited, so mechanism is scored as theoretical only. DMI is a low‑molecular‑weight polar solvent with measurable dermal absorption in typical solvent roles, so topical cosmetic exposure is assessed as moderate. (Sources: ECHA substance page; ECHA Registry of CLH intentions; supplier SDS/C&L notifications; EWG summary).
dimethyl imidazolidinone은 모유 수유 중 안전한가요?
Same hazard basis as pregnancy (listed as Repr. Cat.2 / H361 in registration/SDS material and under active CLH proposal). Mechanism evidence is limited. Dermal/topical exposure could lead to systemic exposure (moderate expected dermal absorption), so breastfeeding exposure is scored as moderate (e=2) because systemic maternal exposure could lead to transfer into milk if maternal systemic levels occur.
dimethyl imidazolidinone은 아기 피부에 안전한가요?
Hazard and mechanism scores follow the same evidence (H361 / Repr. Cat.2 reporting and CLH proposal). Because DMI has measurable dermal absorption as a small polar solvent, infant skin (0–3 yr) receives a higher exposure score (+1 per guidance) relative to adults, so exposure is scored high. There is no specific infant toxicity data found to alter hazard or mechanism scores.
VeriMom은 dimethyl imidazolidinone을 어떻게 평가하나요?
VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 dimethyl imidazolidinone을 20/100 (높은 위험)로 평가합니다.
임신 중 dimethyl imidazolidinone 대체 안전 성분은?
유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.

모든 성분표를 2초 만에 확인

VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.

의료 면책 조항

이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.

VeriMom 앱에서 모든 기능을 이용해 보세요